PARABDRUGS Intraday Analysis...

PARABDRUGS Share Price

Open 6.80 Change Price %
High 6.85 1 Day -0.25 -3.62
Low 6.55 1 Week -0.35 -5.00
Close 6.65 1 Month -0.40 -5.67
Volume 10330 1 Year 0.65 10.83
52 Week High 10.40
52 Week Low 5.40
PARABDRUGS Important Levels
Resistance 2 6.93
Resistance 1 6.81
Pivot 6.68
Support 1 6.49
Support 2 6.37
NSE INDIA Most Active Stocks
JPASSOCIAT 17.05 -6.06%
INFIBEAM 119.85 -16.42%
SUZLON 16.10 -1.23%
RCOM 19.90 0.25%
UNITECH 6.65 -4.32%
IBREALEST 201.50 -7.59%
GMRINFRA 16.45 -1.79%
SOUTHBANK 28.60 -2.39%
HFCL 27.95 -4.93%
CAPACITE 342.55 37.02%
More..
NSE INDIA Top Gainers Stocks
CAPACITE 342.55 37.02%
NAGREEKEXP 35.15 19.97%
SHOPERSTOP 500.40 19.68%
LCCINFOTEC 0.35 16.67%
VISASTEEL 19.90 15.70%
TVTODAY 414.45 15.37%
GUFICBIO 83.25 11.90%
SCI 97.95 11.88%
SCI 97.95 11.88%
SCI 97.95 11.88%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
TIFIN 589.55 -25.67%
ADHUNIKIND 63.30 -19.97%
PRAKASHSTL 0.25 -16.67%
INFIBEAM 119.85 -16.42%
VICEROY 19.40 -11.82%
PREMIERPOL 32.35 -11.37%
DAMODARIND 100.25 -10.01%
TINPLATE 224.65 -9.76%
VASWANI 16.90 -9.63%
More..

Parabolic Drugs Limited (NSE: PARABDRUGS)

PARABDRUGS Technical Analysis 5
As on 25th Sep 2017 PARABDRUGS Share Price closed @ 6.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.98 & Strong Sell for SHORT-TERM with Stoploss of 7.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
PARABDRUGS Target for September
1st Target up-side 7.67
2nd Target up-side 8.45
3rd Target up-side 9.23
1st Target down-side 5.43
2nd Target down-side 4.65
3rd Target down-side 3.87
PARABDRUGS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 41.88 Sideways
MFI (14) MFI is 40.21 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 17.04 Range Bound
PSAR Stoploss For Short Sell 7.41
10 Day Avg Volume Traded -61.25 % Less then 10 Day Average Volume
PARABDRUGS Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PARABDRUGS Address
PARABDRUGS
N/A
PARABDRUGS Latest News
Balwan Bansal quits Parabolic Drugs Ltd   Equity Bulls   - 16th Feb 15
How BALLET PUMPS could leave you limping or even missing a toe: Soaring ...   Daily Mail   - 09th Feb 15
Richard Branson should give up on space tourism says rocket scientist   Daily Mail   - 02nd Nov 14
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs   MarketWatch   - 26th Jun 14
Parabolic Drugs updates on CDR application   Moneycontrol.com   - 03rd Apr 13
Parabolic Drugs Ltd's CDR Application approved   Equity Bulls   - 02nd Apr 13
Parabolic Drugs a good bet for long-term play   Economic Times   - 03rd Jan 12
Mr. Vineet Gupta, Executive Director, Parabolic Drugs Ltd.   India Infoline.com   - 28th Mar 11
Parabolic Drugs IPO fully subscribed   Moneycontrol.com   - 17th Jun 10
Parabolic Drugs has a limited product   Moneylife Personal Finance Magazine   - 11th Jun 10
Interactive Technical Analysis Chart Parabolic Drugs Limited ( PARABDRUGS NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parabolic Drugs Limited
PARABDRUGS Business Profile
Parabolic Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 27.17 crore.The company has reported a standalone sales of Rs 117.12 crore and a Net Loss of Rs 22.32 crore for the quarter ended Sep 2013.The company management includes Pranav Gupta - Chairman & Managing Director, Vineet Gupta - Whole Time Director, Balbir Singh Bhasin - Director, Arun Mathur - Director, Nikhil Goel - Director, Balwan Bansal - Director. It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.Its Registered office is at S.C.O 99-100, Top Floor,,Sector 17 - B Chandigarh,Chandigarh - 160017.Their Registrars are Link Intime India Pvt. Ltd.